Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Jun 16, 2020 9:27am

144 Views

Post# 31155017

Level II 9:25 AM EDT

Big Wall 31½ to 32 cents.

Number of Shares		Bid Price
7,000 shares	7,000	0.295
15,000 shares	15,000	0.285
11,000 shares	11,000	0.280
20,000 shares	20,000	0.270
17,000 shares	17,000	0.265
17,000 shares	17,000	0.260
90,000 shares	90,000	0.255
14,000 shares	14,000	0.250
10,000 shares	10,000	0.245
2,000 shares	2,000	0.240

Level two quotes - Ask
Ask Price	Number of Shares
0.295	19,500	19,500 shares
0.300	57,000	57,000 shares
0.310	12,500	12,500 shares
0.315	100,000	100,000 shares
0.320	109,500	109,500 shares
0.325	40,000	40,000 shares
0.330	4,000	4,000 shares
0.335	10,000	10,000 shares
0.340	10,000	10,000 shares
0.345	1,000